Identification of estrogen receptor β as a SUMO-1 target reveals a novel phosphorylated sumoylation motif and regulation by glycogen synthase kinase 3β

Molecular and Cellular Biology

Volumn 32, Issue 14, 2012, Pages 2709-2721

  Picard, Nathalie ^a,b   Caron, Véronique ^a   Bilodeau, Stéphanie ^a,b   Sanchez, Mélanie ^a,b   Mascle, Xavier ^b   Aubry, Muriel ^b   Tremblay, André ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTROGEN RECEPTOR BETA; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; SUMO 1 PROTEIN; UBIQUITIN;

ARTICLE; BREAST CANCER; CANCER CELL; CATALYSIS; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; INHIBITION KINETICS; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SUMOYLATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ESTROGEN RECEPTOR BETA; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; MICE; MODELS, BIOLOGICAL; MUTANT PROTEINS; PHOSPHORYLATION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN; SUMOYLATION;

EID: 84864018984     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06624-11     Document Type: Article

References (51)

1. Abdel-Hafiz H, Takimoto GS, Tung L, Horwitz KB. 2002. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 277: 33950-33956.
2. Avallone R, et al. 2006. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPARγ-dependent pathway. Mol. Endocrinol. 20:3165-3178.
3. Bailey D, O'Hare P. 2004. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279:692-703.
4. Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD. 2002. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108: 345-356.
5. Chauchereau A, Amazit L, Quesne M, Guiochon-Mantel A, Milgrom E. 2003. Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J. Biol. Chem. 278:12335-12343.
6. Cohen P, Frame S. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2:769 -776.
7. Collavin L, et al. 2004. Modification of the erythroid transcription factor GATA-1 by SUMO-1. Proc. Natl. Acad. Sci. U. S. A. 101:8870-8875.
8. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
9. Desterro JM, Rodriguez MS, Hay RT. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2:233-239.
10. Doble BW, Woodgett JR. 2003. GSK-3: tricks of the trade for a multitasking kinase. J. Cell Sci. 116:1175-1186.
11. Doi M, Okano T, Yujnovsky I, Sassone-Corsi P, Fukada Y. 2004. Negative control of circadian clock regulator E4BP4 by casein kinase Iepsilon-mediated phosphorylation. Curr. Biol. 14:975-980.
12. Fox EM, Davis RJ, Shupnik MA. 2008. ERbeta in breast cancer- onlooker, passive player, or active protector? Steroids 73:1039 -1051.
13. Geiss-Friedlander R, Melchior F. 2007. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8:947-956.
14. Ghisletti S, et al. 2007. Parallel SUMOylation-dependent pathways me-diate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25:57-70.
15. Gill G. 2005. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15:536 -541.
16. Gougelet A, Mueller SO, Korach KS, Renoir JM. 2007. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha. J. Steroid Biochem. Mol. Biol. 104: 110-122.
17. Gregoire S, et al. 2006. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281:4423- 4433.
18. Hartman J, Strom A, Gustafsson JA. 2009. Estrogen receptor beta in breast cancer-diagnostic and therapeutic implications. Steroids 74:635- 641.
19. Hartz AM, Madole EK, Miller DS, Bauer B. 2010. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. J. Pharmacol. Exp. Ther. 334:467- 476.
20. Hay RT. 2005. SUMO: a history of modification. Mol. Cell 18:1-12.
21. Hietakangas V, et al. 2006. PDSM, a motif for phosphorylationdependent SUMO modification. Proc. Natl. Acad. Sci. U. S. A. 103:45-50.
22. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. 2002. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419:135-141.
23. Karamouzis MV, Konstantinopoulos PA, Badra FA, Papavassiliou AG. 2008. SUMO and estrogen receptors in breast cancer. Breast Cancer Res. Treat. 107:195-210.
24. Kim JH, Baek SH. 2009. Emerging roles of desumoylating enzymes. Biochim. Biophys. Acta 1792:155-162.
25. Kim KH, et al. 2004. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J. Biol. Chem. 279:51999- 52006.
26. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F. 2001. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 142:4120-4130.
27. Lindberg K, Helguero LA, Omoto Y, Gustafsson JA, Haldosen LA. 2011. Estrogen receptor beta represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity. Breast Cancer Res. 13:R43. doi:10.1186/bcr2865.
28. Maggi A. 2011. Liganded and unliganded activation of estrogen receptor and hormone replacement therapies. Biochim. Biophys. Acta 1812:1054- 1060.
29. Mascle XH, Germain-Desprez D, Huynh P, Estephan P, Aubry M. 2007. Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the co-repressor of the KRAB multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain. J. Biol. Chem. 282:10190 -10202.
30. Mohideen F, et al. 2009. A molecular basis for phosphorylationdependent SUMO conjugation by the E2 UBC9. Nat. Struct. Mol. Biol. 16:945-952.
31. Picard N, et al. 2008. Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-AP ubiquitin ligase recruitment to the estrogen receptor beta. Mol. Endocrinol. 22:317-330.
32. Pichler A, et al. 2005. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 12:264 -269.
33. Poukka H, Karvonen U, Janne OA, Palvimo JJ. 2000. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. U. S. A. 97:14145-14150.
34. Rodrigue-Way A, Demers A, Ong H, Tremblay A. 2007. A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes. Endocrinology 148:1009 -1018.
35. Rodriguez MS, Dargemont C, Hay RT. 2001. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:12654 -12659.
36. Sanchez M, Picard N, Sauvé K, Tremblay A. 2010. Challenging estrogen receptor beta with phosphorylation. Trends Endocrinol. Metab. 21:104- 110.
37. Sanchez M, Picard N, Sauve K, Tremblay A. Coordinate regulation of estrogen receptor beta degradation by Mdm2 and CREB-binding protein in response to growth signals. Oncogene, in press.
38. Sanchez M, Sauvé K, Picard N, Tremblay A. 2007. The hormonal response of estrogen receptor beta is decreased by the PI3K/Akt pathway via a phosphorylation-dependent release of CREB-binding protein. J. Biol. Chem. 282:4830-4840.
39. Sanchez M, Tremblay A. 2005. Growth factor signaling to estrogen receptors in hormone dependent cancers. Mol. Genet. Cancer 5:149 -185.
40. Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A. 2009. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. Cancer Res. 69:5793-5800.
41. Seeler JS, Dejean A. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4:690-699.
42. Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L. 2005. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol. Endocrinol. 19:2671-2684.
43. St-Laurent V, Sanchez M, Charbonneau C, Tremblay A. 2005. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway. J. Steroid Biochem. Mol. Biol. 94:23-37.
44. Sundqvist A, et al. 2005. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 1:379 -391.
45. Tremblay A, Tremblay GB, Labrie F, Giguere V. 1999. Ligandindependent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol. Cell 3:513-519.
46. Tremblay AM, Wilson BJ, Yang XJ, Giguere V. 2008. Phosphorylationdependent sumoylation regulates ERRα and γ transcriptional activity through a synergy control motif. Mol. Endocrinol. 22:570 -584.
47. Tremblay GB, Tremblay A, Labrie F, Giguère V. 1999. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor α-β heterodimeric complex. Mol. Cell. Biol. 19:1919 -1927.
48. Treuter E, Venteclef N. 2011. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochim. Biophys. Acta 1812:909 -918.
49. Vu EH, Kraus RJ, Mertz JE. 2007. Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1. Biochemistry 46:9795-9804.
50. Ward RD, Weigel NL. 2009. Steroid receptor phosphorylation: assigning function to site-specific phosphorylation. Biofactors 35:528 -536.
51. Yang SH, Galanis A, Witty J, Sharrocks AD. 2006. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25:5083-5093.